Figure 2.

24 hours of closed-loop system versus sensor-augmented pump therapy in adults with type 1 diabetes. Median sensor glucose concentrations (solid red line) and interquartile ranges (red-brown shaded area) during closed-loop insulin delivery and sensor-augmented pump therapy (dark blue line and blue shaded area). Target glucose range between 3·9 and 10 mmol/L (70-180 mg/dL) (dashed lines). Reprinted from The Lancet Healthy Longevity, Vol. 3(3):e135-e142, Boughton. C et al Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study. Lancet Healthy Longevity. Copyright 2022 Mar; 3(3):e135-e142 (12) with permission from Elsevier.